|
|
Recognizing the Next Generation of Life Science & Healthcare Innovators Nominations due this week! |
|
|
Congratulations to our first Rising Star! |
|
|
BioNTX is proud to spotlight emerging leaders in life sciences and healthcare innovation through the Rising Stars program at the iC³ Summit. This program honors entrepreneurs, startups, and researchers making a significant impact.
Nominees should meet the following criteria:
|
|
Nominate a Life Sciences Leader for the 2025 iC³ Dennis K. Stone Award |
|
|
Circa 2002, (from left to right) Jonathan Graff, MD, PhD, and Dennis K. Stone, MD |
|
Dennis K. Stone played a transformative role in shaping the biotechnology landscape, driving innovation, mentoring future leaders, and connecting academic research with industry to accelerate life science advancements.
To honor his legacy, BioNTX presents the Dennis K. Stone Award to individuals who have made significant contributions to the biotechnology industry. This recognition celebrates those who advance life science research and inspire others to do the same. |
|
GROUNDBREAKING NEWS |
|
At BioNTX, we are proud to spotlight key developments that reflect the strength, vision, and diversity of our region’s life science ecosystem. The stories below represent more than headlines—they highlight the pioneering research, breakthrough technologies, and bold entrepreneurs that make North Texas a uniquely powerful force in biotech and healthcare innovation. |
|
Texas Named Nation’s Best Business Climate for Third Straight Year |
|
|
Texas has been recognized by Business Facilities magazine as having the Best Business Climate in the U.S. for 2025, marking the third consecutive year of this honor. The state’s advantages include no corporate or personal income tax, a skilled and diverse workforce, strong infrastructure, and a business-friendly regulatory environment.
In 2024, Texas attracted over 1,300 qualified capital investment projects, with more than 20 companies announcing plans to relocate their corporate headquarters to the state. The ranking evaluates economic development activity, job creation, and factors such as regulatory climate and workforce availability. |
|
Alloy Therapeutics Future Founder Fellowship Launches in North Texas in Fall 2025 |
|
|
The Alloy Future Founder Fellowship will bring world-class faculty, speakers, and a global curriculum to DFW, spotlighting the region as a rising biotech hub. By engaging top scientific and venture leaders, the program plans to bolster North Texas's visibility among investors, founders, and institutions
Alloy Future Founder Fellows will lead two Biotech Startup Academy cohorts: Fall 2025 (October 2 - November 14) and Spring 2026 (TBD).
Each 7-week hybrid program will host a dynamic mix of researchers, faculty, students, postdocs, and industry professionals exploring or launching lite science ventures. |
|
Caris Life Sciences' Nasdaq Debut Marks Milestone for Texas Biotech |
|
|
Caris Life Sciences, a biotech company based in Irving, Texas, has officially gone public on the Nasdaq under the ticker CAI. The company applies artificial intelligence to tissue- and blood-based molecular profiling to advance cancer diagnosis and treatment.
Founded in 2008, Caris has processed millions of tests and recently expanded its capabilities with a new liquid biopsy lab in Phoenix to support its Caris Assure platform. The company’s public debut marks a major milestone for North Texas’ growing life sciences and health tech sector. |
|
|
|
Kelly Cloud, VP of Economic Development, Life Sciences, Dallas Regional Chamber |
|
Transforming Health, Climate, and Community in the Southwestern Medical District |
|
|
|
|
The Southwestern Medical District is undergoing a transformative redevelopment—led by the Texas Trees Foundation and a coalition of public, private, and philanthropic partners—to reimagine how innovation, health, and environment intersect in one of the nation’s leading medical hubs.
This initiative applies cutting-edge, evidence-based urban design to revitalize the Harry Hines Corridor with smart infrastructure, biophilic principles, and climate-responsive strategies. From advanced stormwater systems to data-informed green space planning, the project integrates nature and technology to support public health, mobility, and environmental resilience. |
|
Texas High School Student Develops AI Tool for Early Cancer Detection |
|
|
|
Sachchit Balamurugan |
|
Sachchit Balamurugan, an incoming senior at Texas Online Preparatory School (TOPS) in Little Elm, is earning international recognition for his groundbreaking work in cancer diagnostics.
He has developed an artificial intelligence model that integrates MRI imaging, transcriptomic data, convolutional neural networks (CNNs), and interpretable AI to improve early detection of adrenocortical carcinoma (ACC), a rare and aggressive cancer. |
|
UTSW Discovery Will Lead to Less Toxic Blood Cancer Therapies |
|
|
Researchers at UT Southwestern, including Nobel Laureate Dr. Bruce Beutler, have uncovered how the protein midnolin enables blood cancers such as leukemia and lymphoma to survive.
Using cryo-electron microscopy, the team mapped midnolin’s structure and discovered it manipulates the cell’s protein disposal system to protect cancer cells from damage. In laboratory models, disabling midnolin eliminated up to 92% of cancer cells while sparing healthy cells, highlighting a promising target for more precise and less toxic cancer treatments. |
|
|
Bruce Beutler, MD, UTSW, Nobel Laureate |
|
BioNTX Members Named Among Fort Worth’s Most Influential |
|
|
|
(from left to right) Jennifer Cowley, PhD, MS, FAICP of The University of Texas at Arlington, Cameron Cushman of Cx Precision Medicine, Ryan Brown of TechFW, Sid O'Bryant, PhD of UNT Health Science Center, Sulagna Bhattacharya, MBA of Nanoscope Therapeutics and Paul Dorman, JD of DFB Pharmaceuticals |
|
BioNTX proudly celebrates our Members who continue to shape the future of life sciences and strengthen the North Texas innovation ecosystem through their vision and leadership.
Fort Worth Inc. has released its list of the 500 Most Influential People in Fort Worth, a lineup of changemakers leading the way in economic development, education, healthcare, life sciences, and more. These individuals are driving real progress across Tarrant County and beyond, and we are honored to see our community represented among them. |
|
INSIDE INNOVATION BY ERIC B. MOORE, BIONTX'S CHIEF COMMUNICATIONS OFFICER |
|
Inside Innovation is the narrative thread that runs through the heart of North Texas’ life sciences ecosystem. This section goes beyond headlines to share the stories behind the science, inside the science, and because of the science—highlighting the breakthroughs, the challenges, and the people driving innovation across our region. Here, you will find the depth and perspective that bring our ecosystem to life, the way only BioNTX can. Whether it is a behind-the-scenes look at a new partnership, a founder's unfiltered journey, or reflections on what’s emerging across our innovation landscape, Inside Innovation delivers the depth, dimension, and dialogue you have come to expect from BioNTX.
|
|
Awareness as Infrastructure: Understanding Policy's Role in Our Ecosystem |
|
In the world of life sciences, we often think of infrastructure as physical—labs, incubators, data networks, manufacturing facilities. But there is another kind of infrastructure just as vital, though less visible: policy.
As the 89th Texas Legislative Session concludes, we at BioNTX are reflecting on the quiet but powerful relationship between public policy and regional innovation. We believe deeply in awareness—in ensuring that those who make up our ecosystem understand the broader landscape shaping our collective trajectory.
Policy is not just something that happens in Austin or Washington. It is a framework that influences whether an idea makes it from bench to bedside. It impacts how quickly new therapies reach patients, how companies attract investment, how talent is trained and retained, and how scientific breakthroughs translate into economic growth.
In other words: policy creates conditions. And as we see in nature, and in innovation, conditions matter.
For a thriving biotech ecosystem like North Texas, staying informed about those conditions is part of our responsibility as a community. Whether you are a founder, a researcher, a clinician, a corporate leader, or a student, being attuned to the policy environment is not about politics—it is about positioning. It is about understanding the levers that accelerate or slow the movement of science, ideas, and industry.
The good news is, we do not all need to be policy experts. But we do need to be ecosystem-aware. We need to remain connected to the conversations that shape our future—not to take sides, but to make sense of the system we are working to build.
As BioNTX continues to amplify the voice of North Texas in the life sciences sector, we encourage you to explore the outcomes of the 89th Legislature and consider how they intersect with your work, your goals, and your place in the larger innovation story.
Awareness, after all, is a form of infrastructure. And strong infrastructure is what makes ecosystems not only grow—but last. |
|
EVENT RECAP |
|
BioNTX at BIO International 2025: Advancing Texas Innovation on the Global Stage |
|
|
Earlier this month, BioNTX joined innovators, investors, and thought leaders from around the world at the BIO International Convention, held June 15–19. As part of the Texas Pavilion, we proudly represented North Texas’ growing life sciences and biotech ecosystem, while contributing to the broader visibility of the State of Texas as a competitive force in global biotech.
Our role at the convention extended far beyond exhibit hall presence. From one-on-one meetings and industry breakfasts to private dinners and strategic panels, BioNTX was at the table—amplifying the voice of our members, our mission, and our region’s leadership in innovation, capital, and collaboration.
Whether we were engaging with international companies exploring U.S. market entry, reconnecting with national partners, or promoting the upcoming iC³ Summit, one theme remained consistent: North Texas has momentum—and BioNTX is helping lead the charge.
We are grateful to THBI (Texas Healthcare and Bioscience Institute) for their leadership in organizing the Texas Pavilion and fostering a unified presence for our state. We are equally proud of the strong show of support from our region, and we return energized by the new opportunities, partnerships, and visibility generated throughout the week.
Stay tuned as we continue to convert these engagements into real impact—for our members, for our ecosystem, and for the future of biotech in Texas. |
|
|
Australia: A Strategic Advantage for Accelerating Clinical Development |
|
|
|
|
BioNTX recently welcomed an Australian delegation to North Texas for an in-depth discussion on how Australia’s clinical research ecosystem can help companies dramatically reduce timelines for early-phase regulatory approvals. With a globally respected regulatory framework, streamlined ethics and governance processes, and a robust R&D tax incentive, Australia stands out as a powerful launchpad for companies seeking to expedite the path from discovery to data.
By leveraging Australia’s pragmatic regulatory environment—where first-in-human trials can often begin months ahead of U.S. timelines—companies can generate the high-quality clinical data needed for global submissions more efficiently and cost-effectively.
The session featured insights from Etira and Island Pharmaceuticals, two North Texas-based companies that shared their firsthand experience conducting trials in Australia. Their reflections underscored not only the financial advantages, but also the strategic timing benefits of tapping into Australia’s clinical research infrastructure.
Thank you for your support |
|
|
BIONTX PRESENTS: COMING SOON |
|
Chronic Disease Day Gathers Leaders and Patient Advocates July 10, 2025 |
|
|
|
|
BioNTX and Good Days invite you to an exclusive luncheon symposium on Thursday, July 10 at Pegasus Park, bringing together senior leaders in biotech and healthcare, patient advocates, and key community stakeholders.
This gathering will spotlight urgent federal priorities in chronic illness care, unveil new regional partnerships, and explore bold opportunities to expand access to breakthrough treatments. |
|
From Bench to Buildout: Facility Pathways for Growing Life Science Companies July 22, 2025 |
|
|
|
Join the BioNTX Facilities Advisory Committee for a discussion on how life science startups can successfully graduate from early-stage research to full-scale production.
This session will feature insights from industry experts on the range of options available to growing companies — from leveraging spaces like BioLabs, to partnering with CDMOs, to building or renovating dedicated facilities. Whether you are a startup, founder, developer, or part of an incoming or expanding company, this session will provide valuable guidance on planning for growth and long-term infrastructure needs. |
|
Reconnect: An Evening for the Life Sciences Community July 29, 2025 |
|
|
|
|
The way we work has changed—but our need to connect, collaborate, and grow has not. Join fellow professionals from biotech, pharma, and medical device industries for an energizing evening of conversation, connection, and community.
Whether you are fully remote, hybrid, or somewhere in between, this event is your chance to meet peers face-to-face, share insights, and explore what the future of work looks like in life sciences. No panels, no pitches—just great people, engaging discussions, and a chance to build relationships that last beyond the Wi-Fi signal.
Expect good company, light refreshments, and a few surprises—let’s reconnect and reimagine what is next, together. |
|
Meet, Connect, and Grow: BioNTX Talent Network for Job Seekers August 20 - 21, 2025 |
|
|
The BioNTX Talent Network Meet & Greet is an opportunity for life science professionals and job seekers to connect, share industry insights, and build relationships that support career growth. Attendees will have the chance to network with peers and meet representatives from Catapult Solutions Group, a staffing firm dedicated to helping you navigate your job search and advance your career. |
|
Thank you for your support |
|
|
Explore, Connect, and Refresh with BioNTX Facilities Committee in Grapevine August 27, 2025 |
|
|
|
Join the BioNTX Facilities Advisory Committee for an afternoon of networking and refreshments at McMillan James Equipment Company’s state-of-the-art facility in Grapevine, TX.
|
|
Thank you for your support |
|
|
MEMBER SPOTLIGHT |
|
Powering Life Science Growth |
|
|
Sikich delivers specialized professional services to life science companies, helping them navigate regulatory complexity, streamline operations, and scale with confidence. With strengths in ERP/CRM implementation, compliance, tax strategy, and digital transformation, Sikich supports biotechs and medtech firms from early-stage development through commercialization.
Ranked among the largest CPA firms in the U.S., Sikich blends entrepreneurial insight with technical innovation to help clients transform, comply, and grow. |
|
MEMBER NEWS |
|
Bracane Awarded Silver Medal for Excellence in Sustainability |
|
|
Bracane Company, Inc., a healthcare research and consulting firm based in the U.S., has been awarded a Silver Medal in the 2025 EcoVadis Sustainability Assessment, placing the company in the top 15% of over 90,000 organizations evaluated globally. The recognition highlights Bracane’s strong performance across key areas including environmental impact, labor and human rights, ethics, and sustainable procurement—reflecting its continued commitment to responsible and equitable business practices. |
|
GL CHEMTEC Opens New GMP Kilo Lab Facility to Support Clinical Trial Supply |
|
|
GL CHEMTEC, a CDMO specializing in advanced chemistry services for the pharmaceutical and biotech industries, has announced the completion of its new Good Manufacturing Practice (GMP) Kilo lab facility. This expansion responds to growing demand for high-quality materials suitable for human clinical trials and enhances the company’s ability to support clients from pre-clinical development through to first-in-human studies and commercialization. |
|
Nanoscope Therapeutics Forms Visionary Advisory Committee to Guide Retinal Care Innovation |
|
|
Nanoscope Therapeutics Inc., a biotechnology company developing gene-agnostic therapies for retinal degenerative diseases, has established its Visionary Advisory Committee (VAC), a group of leading experts in retina treatment and commercialization. The VAC will provide strategic input across scientific, clinical, and community efforts, supporting the advancement of therapies for patients with retinitis pigmentosa (RP) and Stargardt disease (SD). |
|
Obsidian Therapeutics Reports Positive Phase 1 Data for OBX-115 in Advanced Melanoma |
|
|
Obsidian Therapeutics, a clinical-stage biotechnology company developing engineered cell and gene therapies, has reported encouraging Phase 1 results for OBX-115, a novel IL2-sparing engineered TIL therapy, in patients with immune checkpoint inhibitor–resistant advanced melanoma.
Multiple patients experienced confirmed responses at the recommended Phase 2 dose, including at least one complete response. OBX-115 demonstrated a favorable safety profile with no dose-limiting toxicities, ICU transfers, or treatment-related deaths. Most patients were treated with low-dose lymphodepletion, and responses showed signs of durability. |
|
Spark Biomedical Completes Enrollment in Wearable Neurostimulation Trial for Opioid Use Disorder |
|
|
Spark Biomedical has finished enrolling patients in a pivotal trial testing its wearable transcutaneous auricular neurostimulation (tAN®) therapy to improve treatment retention for opioid use disorder. The study, conducted with Hazelden Betty Ford Foundation and Gaudenzia and funded by NIDA, explores tAN’s effectiveness alone and with existing medications. Results will support future FDA review of this drug-free treatment option. |
|
S&W Seed Company Prepares to Launch First Commercial Gene-Edited Alfalfa Following FDA Review |
|
|
S&W Seed Company announced it is set to release the first commercial gene-edited alfalfa varieties in the U.S. following the FDA’s completed review of an altered lignin trait developed in partnership with Cibus, Inc. The FDA confirmed it has no further questions regarding the trait’s use in food or feed, clearing a key regulatory milestone. The new alfalfa varieties, designed to improve digestibility for livestock and offer greater harvest flexibility for farmers, will be available in two dormancy classes. This launch expands S&W’s trait portfolio and reinforces its commitment to advancing innovation in forage crops. |
|
Taconic Biosciences and Helmholtz Munich Partner to Advance CRISPR Gene Editing for Preclinical Research |
|
|
Taconic Biosciences has entered into an exclusive license agreement with Helmholtz Munich to expand its CRISPR gene editing services for preclinical research. Through this partnership, Taconic gains exclusive rights to a patented CRISPR-based technology developed at Helmholtz Munich, aimed at enhancing the precision and efficiency of generating genetically modified animal models. The agreement strengthens Taconic’s ExpressMODEL® platform and reinforces its leadership in delivering advanced gene-editing solutions to biomedical researchers worldwide. |
|
SkinStasis Launches Patented Anti-Aging Serum Featuring Breakthrough Use of Tranexamic Acid |
|
|
|
SkinStasis Skin Care, a Dallas-based company specializing in innovative, science-backed skincare, has launched its Anti-Aging Glow Serum. The formula features 10% Tranexamic Acid—a compound naturally found in the body—along with Niacinamide and Copper Tripeptide. The serum targets fine lines, wrinkles, and skin discoloration while supporting collagen and elastin health. Unlike many anti-aging products, it does not increase sun sensitivity and helps protect skin from sun damage. |
|
Polsinelli Recognized Nationally in IAM Patent 1000 for Sixth Year |
|
|
Polsinelli’s Intellectual Property Department has once again been named to the IAM Patent 1000: The World’s Leading Patent Professionals for 2025, marking its sixth national ranking for excellence in patent prosecution. The firm earned recognition across six U.S. jurisdictions, including national honors and high marks in Colorado, Texas, Washington, Missouri, and the D.C. Metro Area for both litigation and prosecution. Nineteen Polsinelli attorneys were individually ranked among the world’s top patent professionals. |
|
Arlington EDC Launches Certification Reimbursement Program for Small Businesses |
|
|
The Arlington Economic Development Corporation has launched the Arlington Business Certification (ABC) Program to help local small businesses gain industry-recognized certifications that boost competitiveness and open new contracting opportunities. The program offers reimbursements of up to $650 for certifications such as SBA 8(a), SBE, WBE, and veteran-owned business credentials. Eligible Arlington-based businesses can apply through certifying partners including the SBA, NCTRCA, DFW MSDC, and the Women’s Business Council Southwest. |
|
UT Arlington Researchers Use AI to Boost Physical Activity in Cancer Survivors |
|
|
A research team at The University of Texas at Arlington has received a grant from the Cancer Prevention and Research Institute of Texas (CPRIT) to develop an AI-driven system that encourages physical activity among cancer survivors.
The project will use data from smartphones and wearable devices to deliver personalized, real-time messages designed to motivate movement. Led by faculty from kinesiology, communication, and computer science—with collaboration from MD Anderson—the initiative aims to create scalable, cost-effective behavioral interventions using machine learning. |
|
Four UT Dallas Alumni Awarded 2025 NSF Graduate Research Fellowships |
|
|
Four UT Dallas graduates received the prestigious NSF Graduate Research Fellowships, which provide tuition and a three-year stipend to support advanced STEM studies. Varun Gunda and Zachary Lee, from Dr. Shalini Prasad’s lab, will pursue research in tissue regeneration and medical devices. Brandon Sike focuses on astrophysics, and Harish Suryadevara studies organic molecules for health.
The fellowship allows them to dedicate themselves fully to their groundbreaking research, reflecting the strong mentorship and research environment at UT Dallas. |
|
UTSW Scientists Reveal Vitamin E Shielding Mechanism in Tumors |
|
|
Researchers at UT Southwestern’s Children’s Medical Center Research Institute (CRI) have discovered that tumors use a unique mechanism involving sulfated glycosaminoglycans (GAGs) to capture lipoproteins carrying vitamin E, an antioxidant that shields cancer cells from oxidative stress and promotes survival. This nontraditional pathway allows cancer cells to resist ferroptosis, a form of cell death triggered by toxic lipid buildup.
By blocking GAG production, the team slowed tumor growth and increased cancer cells’ vulnerability to treatment. Studies on patient kidney tumors confirmed elevated GAG and vitamin E levels compared to normal tissue, highlighting this pathway as a promising therapeutic target. |
|
FUNDING & MENTORSHIP OPPORTUNITIES |
|
Advancing Early-Stage Innovation in Rare Cancers Application closes July 1, 2025 |
|
|
The Fiscal Year 2025 (FY25) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) supports innovative, early-stage research ideas with the potential to generate impactful data and open new avenues for investigation. |
|
Funding Bold Ideas to Advance Duchenne Muscular Dystrophy Research Letter of Intent due July 25, 2025 |
|
|
The FY25 Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) is designed to spark bold, early-stage research with the potential to transform the landscape of Duchenne muscular dystrophy (DMD). This award supports high-risk, high-reward ideas that are conceptually innovative and could lead to groundbreaking discoveries or new research directions that significantly improve outcomes for individuals living with DMD. |
|
NIH Director’s Pioneer Award Program (DP1 Clinical Trial Optional) Application due September 9, 2025 |
|
|
The NIH Director’s Pioneer Award supports individual scientists of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. To be considered pioneering, the proposed research must reflect substantially different scientific directions from those already being pursued in the investigator’s research program or elsewhere. Applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. The NIH Director’s Pioneer Award is a component of the High-Risk, High-Reward Research (HRHR) Program of the NIH Common Fund. |
|
Addressing Rare Diseases Topical PCORI Funding Announcement -- Cycle 3 2025 Letter of Intent due September 23, 2025 |
|
|
The Patient-Centered Outcomes Research Institute (PCORI) intends to issue a PCORI Funding Announcement (PFA) on August 12, 2025, seeking to fund high-quality, patient-centered comparative clinical effectiveness research (CER) studies that focus on rare diseases. This preannouncement provides potential applicants additional time to identify collaborators; obtain patient and stakeholder input on potential studies; and develop responsive, high-quality proposals. |
|
Propionic Acidemia Foundation Application closes October 1, 2025 |
|
|
PAF is a non-profit organization whose primary mission is to help advance research devoted to finding treatments and a cure for propionic acidemia. By funding research, we aim to accelerate new knowledge, discovery, development and/or evaluation of therapeutics leading to better treatment and a cure for all individuals affected by PA.
Funding available for Research projects and Post-Doctoral Fellows Program. |
|
Fueling the Next Generation of Health Innovators Application closes March 6, 2026 |
|
|
The One Health Incubator is a dynamic partnership between the Innovation Hub and the Health Sciences Center, created to support researchers and technology startups in the life sciences sector. This collaborative platform combines institutional expertise to offer an ecosystem of incubation, mentorship, and strategic connections—tailored specifically for life science innovators.
Startups and researchers benefit from access to state-of-the-art facilities, specialized resources, and guidance from industry experts. The incubator helps accelerate the development and commercialization of innovative healthcare solutions while fostering valuable relationships with potential partners, investors, and mentors. |
|
NIH Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions Program ends January 8, 2027 |
|
|
The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students, and enhancing the research environment at applicant institutions. |
|
iC³ SUMMIT NEWS & UPDATES |
|
Save The Date: September 2025 |
|
|
|
The iC³ Life Science Summit is an event that brings together leaders and innovators from the life sciences and healthcare sectors to discuss challenges, discover new opportunities, and drive transformation.
As we look ahead to the 2025 iC³ Life Science & Healthcare Innovation Summit, we are celebrating “10 Years and Beyond” with a focus on the cutting-edge intersection of biology, technology, and artificial intelligence (AI). This convergence is powering breakthroughs in precision medicine, biomanufacturing, and other fields shaping the future of healthcare. |
|
|
Dates Tuesday, September 16: 7:00am - 7:00pm Wednesday, September 17: 8:00am - 3:30pm |
|
Location Hilton Anatole 2201 N Stemmons Freeway, Dallas, TX 75207 |
|
Applications Now Open for the 4th Annual Tech Transfer Showcase at BioNTX's iC³ Life Science Summit Application closes on July 28, 2025 |
|
Present your groundbreaking innovations at the 4th Annual Tech Transfer Showcase during BioNTX's iC³ Life Science Summit, an exclusive platform designed to connect academic institutions from Texas, Arkansas, Louisiana, New Mexico, Oklahoma, and Tennessee with top industry leaders and investors.
This event offers a unique opportunity to highlight your most promising intellectual property, explore potential collaborations, and secure funding, all while advancing the future of life sciences and technology. |
|
INDUSTRY EVENTS |
|
Upcoming Events & Opportunities |
|
|
Health Wildcatters Summer Community Happy Hour & Ribbon Cutting
Join the Health Wildcatters for an evening of celebration and networking. Come meet fellow healthcare enthusiasts, enjoy refreshing drinks and delicious hor dourves, and witness the official ribbon cutting for our recently completed office expansion.
July 10th | Dallas, TX |
|
|
Chronic Disease Day Healthcare and Biotech Leadership Summit
Join Good Days for their National Chronic Disease Day Luncheon Symposium at the ARPA-H Customer Experience Hub in Dallas, Texas, just as the federal government intensifies its focus on chronic illness as a national priority.
July 10th | Dallas, TX |
|
|
Presents
So You Think You Need a Facility?
Join the BioNTX Facilities Advisory for a discussion on how life science startups can successfully graduate from early-stage research to full-scale production.
July 22nd | Dallas, TX |
|
|
Reconnectiong: The Future of Work Together - A Networking Event for Life Sciences Professionals
Join fellow professionals from biotech, pharma, and medical device industries for an energizing evening of conversation, connection, and community.
July 29th | Arlington, TX |
|
|
DFW Startup Week 2025
Join DFW Startup Week, which brings together entrepreneurs and change-makers for a week-long experience. This event is described as the largest entrepreneurial event in North Texas, where they exchange ideas, collaborate, and grow alongside the 10th largest startup ecosystem in the US.
August 3rd - 7th | Dallas, TX |
|
|
Rose Gala 2025
Join To Cure a Rose for the Rose Gala — an inspiring and unforgettable evening in support of To Cure A Rose Foundation. Set against the stunning backdrop of the Omni Barton Creek Resort, this exclusive event brings together elegance, entertainment, and purpose.
August 9th | Austin, TX |
|
|
Q3 2025 BHIANT Quarterly Meeting
Join BHIANT for their second quarterly meeting of 2025. Meet with other industry leaders and collaborate to tackle pressing challenges, redefine shared goals, and strengthen the biotech and healthcare ecosystem across North Texas.
August 19th | Dallas, TX |
|
|
Presents
2025 Talent Network Meet & Greet - Arlington
Join BioNTX for the Talent Network Meet & Greet in Arlington, where job seekers can connect with others in their field, share insights to grow their network, and meet with Catapult Solutions Group, a staffing firm that can support their job search & help advance their career journey.
August 20th | Arlington, TX |
|
|
Presents
2025 Talent Network Meet & Greet - Dallas
Join BioNTX for the Talent Network Meet & Greet in Dallas, where job seekers can connect with others in their field, share insights to grow their network, and meet with Catapult Solutions Group, a staffing firm that can support their job search & help advance their career journey.
August 21st | Dallas, TX |
|
|
2025 iC³ Life Science & Healthcare Innovation Summit
The annual iC³ Life Science Summit serves as North Texas’ premier platform for the bioscience community, uniting industry and academic leaders to discuss breakthrough research, share insights, and connect over cutting-edge technologies shaping the future of healthcare.
September 16th - 17th | Dallas, TX |
|
Happy July 4th Week & Weekend from BioNTX As we head into the holiday weekend, BioNTX celebrates the spirit of independence, innovation, and community that drives our life sciences ecosystem forward. Wishing you a safe, joyful, and restful July 4th week & weekend with family and friends. |
|
|
June 30, 2025 |
|
